Thematic photoMartin FalbisonerCC BY-SA 3.0Resized, encoded as WebP; displayed with responsive cropping under the original licenceSEC EDGAR published this disclosure on 2026-07-29. Read the original document for its full text and supporting detail.
Open the original document at SEC EDGAR ↗accession0001193125-26-323842
acquired disposedA
codeM
direct or indirectD
form4
is derivativefalse
issuer nameASHLAND INC.
labelExercise of derivative
Source record & verificationDates, provenance and technical details
Context
links are based on the recorded entity typeRecorded payloadStructured source data
Recorded payload
JSON payload as stored after parsing{
"accession": "0001193125-26-323842",
"acquired_disposed": "A",
"code": "M",
"direct_or_indirect": "D",
"form": "4",
"is_derivative": false,
"issuer_name": "ASHLAND INC.",
"label": "Exercise of derivative",
"person_name": "Assis Alessandra Faccin",
"price": 66.38,
"role": "SVP and GM, Life Sciences",
"security": "Common Stock",
"shares": 3215,
"shares_owned_after": 9099,
"source_path": "edgar/data/1674862/0001193125-26-323842.txt",
"ticker": "ASH",
"value": 213411.7
}Evidence-based analysis
facts, provenance and explicit model coverageDescriptive evidence from the stored source record; it is not advice, a forecast or a legal conclusion.